News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,907 Results
Type
Article (87300)
Company Profile (739)
Press Release (770842)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (232998)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91222)
Employer Resources (202)
FDA (18258)
Job Trends (17392)
News (397262)
Policy (39909)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (121)
Alliances (56979)
ALS (139)
Alzheimer's disease (1657)
Antibody-drug conjugate (ADC) (209)
Approvals (18263)
Artificial intelligence (466)
Autoimmune disease (51)
Automation (24)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (154)
Biotechnology (484)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (453)
Cancer (3630)
Cardiovascular disease (319)
Career advice (3551)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (643)
Cervical cancer (31)
Clinical research (75059)
Collaboration (1317)
Company closure (4)
Compensation (876)
Complete response letters (56)
COVID-19 (2946)
CRISPR (80)
C-suite (522)
Cystic fibrosis (130)
Data (3948)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (437)
Diagnostics (7064)
Digital health (31)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (225)
Drug pricing (171)
Drug shortages (36)
Duchenne muscular dystrophy (187)
Earnings (98660)
Editorial (53)
Employer branding (25)
Employer resources (171)
Events (132531)
Executive appointments (961)
FDA (20560)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1167)
Gene editing (167)
Generative AI (45)
Gene therapy (510)
GLP-1 (1004)
Government (5359)
Grass and pollen (7)
Guidances (334)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (54)
Immunology and inflammation (231)
Immuno-oncology (19)
Indications (50)
Infectious disease (3170)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (89)
Intellectual property (175)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (629)
Leadership (31)
Legal (10145)
Liver cancer (91)
Longevity (12)
Lung cancer (518)
Lymphoma (252)
Machine learning (25)
Management (66)
Manufacturing (592)
MASH (124)
Medical device (14842)
Medtech (14860)
Mergers & acquisitions (22691)
Metabolic disorders (1108)
Multiple sclerosis (131)
NASH (23)
Neurodegenerative disease (198)
Neuropsychiatric disorders (53)
Neuroscience (2608)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (549)
Opinion (304)
Ovarian cancer (122)
Pain (157)
Pancreatic cancer (155)
Parkinson's disease (222)
Partnered (28)
Patents (394)
Patient recruitment (279)
Peanut (57)
People (66106)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23139)
Phase II (32600)
Phase III (24528)
Pipeline (2543)
Policy (284)
Postmarket research (3554)
Preclinical (10447)
Press Release (72)
Prostate cancer (181)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (625)
Real estate (7416)
Recruiting (78)
Regulatory (27796)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (66)
Schizophrenia (123)
Series A (194)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (96)
Tariffs (85)
The Weekly (105)
Vaccines (1020)
Venture capital (64)
Weight loss (383)
Women's health (57)
Worklife (21)
Date
Today (93)
Last 7 days (513)
Last 30 days (2509)
Last 365 days (33817)
2025 (24446)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50846)
Australia (8931)
California (9055)
Canada (2759)
China (858)
Colorado (383)
Connecticut (405)
Delaware (248)
Europe (116802)
Florida (1331)
Georgia (306)
Hawaii (3)
Idaho (67)
Illinois (792)
India (47)
Indiana (444)
Iowa (19)
Japan (283)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (75)
Maryland (1230)
Massachusetts (6803)
Michigan (302)
Minnesota (549)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (104)
New Hampshire (76)
New Jersey (2503)
New Mexico (32)
New York (2470)
North Carolina (1376)
North Dakota (10)
Northern California (4039)
Ohio (283)
Oklahoma (19)
Oregon (50)
Pennsylvania (1887)
Puerto Rico (19)
Rhode Island (45)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3454)
Tennessee (144)
Texas (1413)
United States (33564)
Utah (270)
Virginia (239)
Washington D.C. (82)
Washington State (781)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 858,907 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Hansa Kidney Transplant Drug Aces Phase III Study, Headed to FDA
Imlifidase, an IgG-destroying enzyme, could receive FDA approval in the second half of 2026 and hit peak sales of $306 million, according to William Blair.
September 26, 2025
·
2 min read
·
Tristan Manalac
Breast cancer
Lilly’s Oral SERD Wins FDA Go-Ahead for Breast Cancer
Phase III data showed that Inluriyo improves progression-free survival versus standard endocrine therapy.
September 26, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Sets 100% Pharma Tariff Deadline for October 1
Companies that have broken ground on or are actively constructing manufacturing facilities in the U.S. are exempted from the tariffs, according to President Donald Trump’s social media post on Thursday.
September 26, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Trump Admin Readies Proposed Rule To Lower US Drug Prices
Though details remain scant, the pending order is expected to be the latest effort in President Donald Trump’s campaign to bring drug prices down to the same level as economically similar countries.
September 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
September 26, 2025
·
6 min read
Press Releases
BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented
September 26, 2025
·
3 min read
Press Releases
Concept Life Sciences Expands Integrated Drug Discovery Facilities
September 26, 2025
·
3 min read
Press Releases
uniQure Announces Pricing of Upsized $300 Million Public Offering
September 26, 2025
·
5 min read
Press Releases
Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
September 26, 2025
·
6 min read
Press Releases
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
September 26, 2025
·
3 min read
1 of 85,891
Next
